Trial intelligence / Profile preview

PF-04136309 in osteoarthritic knee pain

NCT00689273Phase 2Completed

Sponsor
Pfizer
Start
Aug 2008
Primary completion
Nov 2008
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of PF-04136309 in osteoarthritis (OA), sponsored by Pfizer. Started Aug 2008; status: completed.

02

Drugs

PF-04136309
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT00689273.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00689273.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call